TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer
Article in Clinical Colorectal Cancer (June 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Chalcones: An insight into their anticancer potential and action mechanism
Preprint in SSRN Electronic Journal (January 2023)
Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial
Article in European Journal of Cancer (July 2021)